Organisations source: ARIS

Lek Pharmaceutical Company d.d.

Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
4.06.00  Biotechnical sciences  Biotechnology   
1.04.04  Natural sciences and mathematics  Chemistry  Organic chemistry 
1.04.05  Natural sciences and mathematics  Chemistry  Analytical chemistry 
4.04.03  Biotechnical sciences  Veterinarian medicine  Therapy and health prevention of animals 
3.00.00  Medical sciences     

Code Science Field
B740  Biomedical sciences  Pharmacological sciences, pharmacognosy, pharmacy, toxicology 
T490  Technological sciences  Biotechnology 
P390  Natural sciences and mathematics  Organic chemistry 
B007  Biomedical sciences  Medicine (human and vertebrates) 
B750  Biomedical sciences  Veterinary medicine: surgery, physiology, pathology, clinical studies 

Code Description
4  Industry 
Evaluation (metodology)
source: COBISS
Evaluation of bibliographic research performance indicators according to ARIS methodology
Points
4,202.92
A''
1,903.79
A'
3,119.66
A1/2
3,771.37
CI10
7,623
CImax
277
h10
41
A1
17.07
A3
0
Data for the last 5 years (citations for the last 10 years) on August 17, 2026; Data for score A3 calculation refer to period 2020-2024
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 381  11,170  9,821  25.78 
Scopus 389  13,441  12,006  30.86 
Research groups (1)
no. Code Name of group Responsible person No. of publications
1. 0258-001  Raziskovalna skupina Lek (Slovene)  PhD Zdenko Časar   1,188 
Researchers (35)
no. Code Name and surname Research area Status No. of publications
1. 61675  Eva Avsec  Pharmacy  Researcher  0 
2. 25492  PhD Katja Berginc  Pharmacy  Researcher  80 
3. 26453  PhD Petra Cuderman  Pharmacy  Researcher  40 
4. 19281  PhD Zdenko Časar  Chemistry  Researcher  183 
5. 19789  PhD Martin Črnugelj  Chemistry  Researcher  41 
6. 36060  PhD Ivana Gazić Smilović  Pharmacy  Researcher  28 
7. 57761  PhD Vesna Gorenjak  Pharmacy  Researcher  0 
8. 11102  PhD Rok Grahek  Chemistry  Researcher  90 
9. 35432  PhD Darja Gramec Skledar  Pharmacy  Researcher  36 
10. 59115  Martin Rafael Gulin  Biotechnology  Researcher  15 
11. 22306  PhD Matej Horvat  Pharmacy  Researcher  135 
12. 34670  PhD Biljana Janković  Pharmacy  Researcher  145 
13. 19735  Irma Jedlovčnik  Pharmacy  Researcher  3 
14. 60399  PhD Ahmad Joukhan  Pharmacy  Researcher  5 
15. 15235  PhD Aleš Koce  Biology  Researcher  21 
16. 61649  Jurij Kodre  Computer intensive methods and applications  Researcher  0 
17. 60078  PhD Mila Kovačević  Pharmacy  Researcher  17 
18. 53282  Mitja Kožuh  Pharmacy  Researcher  0 
19. 61789  PhD Dejan Krajcar  Natural sciences and mathematics  Researcher  0 
20. 24392  PhD Katja Kristan  Pharmacy  Researcher  98 
21. 20369  PhD Igor Legen  Pharmacy  Researcher  89 
22. 34214  PhD Rok Lenarčič  Biotechnology  Researcher  28 
23. 33193  PhD Peter Mrak  Biotechnology  Researcher  37 
24. 37728  PhD Klemen Naveršnik  Chemistry  Researcher  18 
25. 33194  Matej Ošlaj  Biotechnology  Researcher  10 
26. 23833  PhD Polona Smrdel  Pharmacy  Researcher  18 
27. 61575  Jerneja Strmšek  Pharmacy  Researcher  0 
28. 24449  PhD Damjan Šterk  Chemistry  Researcher  27 
29. 23687  PhD Dušan Teslić  Chemical engineering  Researcher  21 
30. 38304  PhD Marko Trampuž  Chemical engineering  Researcher  34 
31. 30817  PhD Tina Trdan Lušin  Natural sciences and mathematics  Researcher  47 
32. 20679  Matjaž Tršek  Pharmacy  Researcher  0 
33. 61676  Domen Zavec, Ph.D.  Biotechnology  Researcher  0 
34. 50714  PhD Rebeka Žakelj  Pharmacy  Researcher  25 
35. 50718  PhD Nina Žigart  Pharmacy  Researcher  11 
Research projects (30) Legend
no. Code Title Period Responsible person No. of publications
1. L1-8135  Biološka zdravila: detektor tvorbe proteinskih delcev na osnovi tekočih kristalov (Slovene)  5/1/2017 - 4/30/2020  PhD Miha Ravnik   4,003 
2. J4-8226  Modulacija encimskega kompleksa poliketid sintaze v zgodnjih in poznih stopnjah biosinteze tetraciklinskih antibiotikov (Slovene)  5/1/2017 - 4/30/2020  PhD Hrvoje Petković   1,772 
3. L7-8269  Novi pristopi za boljša biološka zdravila (Slovene)  5/1/2017 - 4/30/2020  PhD Janez Konc   3,159 
4. L4-7628  Continuous chromatographic isolation izoforms of monoclonal antibodies  3/1/2016 - 2/28/2019  PhD Aleš Podgornik   1,607 
5. L2-4166  Sinteza dendroniziranih polipeptidov za uporabo v biomedicini (Slovene)  7/1/2011 - 6/30/2014  PhD Ema Žagar   3,585 
6. J4-2212  Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene)  5/1/2009 - 4/30/2012  PhD Nada Kraševec   3,997 
7. L2-2078  Novi dendritski polimeri kot nosilci za kontrolirano dostavo zdravilnih učinkovin (Slovene)  5/1/2009 - 4/30/2012  PhD Ema Žagar   2,376 
8. L4-2286  Razvoj novih oblik nanodelcev TNF-alfa za uporabo v terapiji (Slovene)  5/1/2009 - 4/30/2012  PhD Vladimira Gaberc-Porekar   1,416 
9. L2-1159  Kompleksi nanodelec-makromolekula kot osnova za uporabo v formulaciji bioloških zdravil (Slovene)  2/1/2008 - 1/31/2011  PhD Janko Jamnik   3,033 
10. L2-1112  Tehnologije znanj za odkrivanje novih zdravilnih učinkovin: analiza in načrtovnje eksperimentov v visokozmogljivostni genetiki (Slovene)  2/1/2008 - 1/31/2011  PhD Blaž Zupan   3,336 
11. L1-0378  Cylcic nucleotide phosphodiesterase from Mycobaterium tuberculosis: structure and function  2/1/2008 - 1/30/2011  PhD Marjetka Podobnik   817 
12. L1-9596  Molecular mechanism of novel hypolipidemics  7/1/2007 - 12/31/2008  PhD Uroš Urleb   1,952 
13. J1-7584  Novel Mur ligase inhibitors  9/1/2005 - 8/31/2008  PhD Uroš Urleb   1,133 
14. Z1-7586  Development of Mur Ligase Inhibitors as Novel Antibacterial Agents       9/1/2005 - 8/31/2007  PhD Uroš Urleb   411 
15. Z1-7572  Preclinical development of a novel inhibitor of class A and class C beta-lactamases  9/1/2005 - 8/31/2007  PhD Tomaž Šolmajer   406 
16. J1-6713  Lanosterol 14alpha-demethylase in biosynthesis of cholesterol and signalling sterols  7/1/2004 - 6/30/2007  PhD Damjana Rozman   2,433 
17. L2-6005  Time- and position-controlled release of drug substances coated onto superparamagnetic nanoparticles  7/1/2004 - 6/30/2007  PhD Marjan Bele   3,425 
18. L1-6707  Design, synthesis and test of potencial hypolipidemic drugs with a new target  2/1/2004 - 1/30/2007  PhD Uroš Urleb   3,721 
19. L3-5084  Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)  1/1/2003 - 12/31/2005  PhD Mojca Stegnar   5,917 
20. L1-5292  Razvoj novih inhibitorjev beta laktamaz razreda A in C (NOVACLIN) (Slovene)  1/1/2003 - 12/31/2005  PhD Tomaž Šolmajer   642 
21. L4-3324  Development of TNF-alpha and its analogs for cancer therapy  7/1/2001 - 6/30/2004  PhD Viktor Menart   955 
22. L1-3353  Peptidic inhibitors of lipopolysaccharide  7/1/2001 - 6/30/2004  PhD Primož Pristovšek   436 
23. L1-3261  Development of biologicaly active peptidomimetics  7/1/2001 - 12/31/2003  PhD Uroš Urleb   2,158 
24. L2-3020  Automatic visual inspection of pharmaceutical tablets  12/1/2001 - 11/30/2003  PhD Boštjan Likar   1,555 
25. L1-1532  Modifikacije farmacevtsko pomembnih proteinov za lažjo izolacijo in izboljšanje lastnosti (Slovene)  1/1/1999 - 6/30/2001  PhD Vladimira Gaberc-Porekar   1,652 
26. J1-7374  Načrtovanje in sinteza novih inhibitorjev beta-laktamaze (Slovene)  1/1/1996 - 6/30/2001  PhD Tomaž Šolmajer   738 
27. L1-0469  Optimization of MDP and TNF analogues having therapeutic potential  7/1/1998 - 6/30/2000  PhD Anton Štalc   6,697 
28. J1-8889  Mimetics of biologically active peptides: Strategies of design and synthesis  1/1/1997 - 12/31/1999  PhD Danijel Kikelj   4,059 
29. R1-2891  Razvoj liposomskega pripravka z vgrajenim klindamicinom (Slovene)  1/1/1998 - 10/31/1999  PhD Marjeta Šentjurc   580 
30. L1-7379  Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)  1/1/1996 - 6/30/1998  PhD Anton Štalc   6,411 
ARIS research and infrastructure programmes (3) Legend
no. Code Title Period Responsible person No. of publications
1. P1-0340  Design and preclinical development of novel drugs  1/1/2014 - 12/31/2017  PhD Uroš Urleb   1,561 
2. P1-0340  Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)  1/1/2009 - 12/31/2013  PhD Uroš Urleb   937 
3. P1-0340  Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)  7/1/2006 - 12/31/2008  PhD Uroš Urleb   1,625 
International projects (7) source: SICRIS
no. Code Title Period Responsible person
1. H2020-EU.2.1.4-nextBioPharmDSP-193337  Next-generation biopharmaceutical downstream process  3/1/2015 - 2/28/2019   
2. FP7-NMP-103073  Mucus Permeating Nanoparticulate Drug Delivery Systems  4/1/2012 - 3/31/2016   
3. FP6-NMP-NANOBIOPHARMACEUTICS-81550  Nanoscale Functionalities for Targeted Drug Delivery of Biopharmaceutics  10/1/2006 - 9/30/2010   
4. FP6-LIFESCIHEALTH-EUR-INTAFAR-74098  Inhibition of new targets for fighting antibiotic resistance  1/1/2005 - 6/30/2010  PhD Stanislav Gobec  
5. FP6-LIFESCIHEALTH-STEROLTALK-75692  Functional genomics of complex regulatory networks from yeast to human: cross-talk of sterol homeostasis and drug metabolism  9/1/2005 - 8/31/2008  PhD Damjana Rozman  
6. FP5-LIFE QUALITY-ANTICO-67256  Demonstration of increased yield and productivity in selected commercial organisms by strategic transformation of key genes from aspergillus niger  11/1/2002 - 10/31/2005   
7. FP5-EESD-WATERCATOX-54177  Waste water treatment by catalytic oxidation contactor (WATERCATOX)  1/1/2001 - 3/31/2005   
Mentors for junior researchers (3)
no. Code Name and surname Research area Status
1. 01494  PhD Viktor Menart  Biotechnology  Researcher 
2. 01661  PhD Tomaž Šolmajer  Chemistry  Researcher 
3. 05088  PhD Manica Černe  Veterinarian medicine  Researcher 
Confirmation required
Views history
Favourite